Business Success Action Group

As the US government stepped up its support to India in its fight against a deadly wave of COVID-19, an Indian public health expert pointed out the enormous scope for collaboration between India and the US on health technology and pharmaceuticals. "Now that we are out of the crisis, health technology and pharmaceuticals are two areas where there is tremendous scope for India-US collaboration," said Indian official Dr. Mrinalini Darswal, who is currently doing a PhD in public health with a focus on COVID-19 at Harvard University, tells. Darswal, a 2002 IAS officer for Odisha cadres, said India had demonstrated its expertise in the health sector, particularly in terms of speed of innovation, manufacturing and cost efficiency. It would be beneficial for the US to leverage India's technical expertise and installed drug manufacturing capabilities to source healthcare equipment, drugs, personal protective equipment and vaccines now at competitive prices, she said. "